Peer Schatz
Angel Investor
Düsseldorf, Germany
Peer Schatz is a seed investor in Düsseldorf focused on Medical and Health Care. 1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Peer Schatz invests in
Stages Peer Schatz invests in
Countries Peer Schatz invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (100%)
- Health Care 2 (100%)
- Genetics 1 (50%)
- Oncology 1 (50%)
- Biotechnology 1 (50%)
Country
- United States 1 (50%)
- United Kingdom 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development. It leverages human genetics and clinical omics data and utilizes patient-derived tissue samples with functional genomics interventional experiments to identify, validate, and prosecute therapeutic programs. | $25M / Seed / Jun 09, 2022 | ||
| Valar Labs makes AI to interpret solid tumors and deliver insights, so physicians and patients can make informed treatment decisions. Their AI algorithms analyze digitized pathology slides to assess spatial features, and they design transparent systems grounded in underlying biology so physicians can trust the results. | $4M / Seed / Mar 30, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Peer Schatz invest in?
Peer Schatz invests primarily in Medical, Health Care and Genetics startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Peer Schatz?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Peer Schatz last invest?
The most recent investment recorded for Peer Schatz closed in Jun 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
